Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Birddogfishman's Profile
Displaying 1-6 of 6 result(s).
GNBTQ Generex Biotechnology Corp.
02/04/2022 7:14:13 PM
Great Find. Now why would a company (4)
GNBTQ Generex Biotechnology Corp.
12/22/2021 8:54:46 PM
Spinner, I agree and disagree to an (6)
GNBTQ Generex Biotechnology Corp.
12/17/2021 7:34:27 PM
Skipper, Although not an exact perc
GNBTQ Generex Biotechnology Corp.
12/17/2021 12:59:06 PM
Consider me one of the people that (6)
GNBTQ Generex Biotechnology Corp.
11/24/2021 11:29:56 PM
Agreed, I remain guardingly optimis (1)
GNBTQ Generex Biotechnology Corp.
11/23/2021 9:27:30 PM
Another company that I am invested (6)

Recent Articles

  • Understanding iOThree Limited's Compliance Notification from Nasdaq
  • Captivision, Inc. Faces Nasdaq Compliance Challenges Ahead
  • The Children’s Place Reflects on First Quarter 2025 Outcomes
  • Marimaca Copper Corp. Delivers Positive AGM Voting Results
  • Fulcrum Therapeutics Announces New Employee Stock Options Grant
  • ORIC Pharmaceuticals' New Employee Incentive Programs Explained
  • Talisker Resources Secures $14 Million Private Placement Funds
  • Zealand Pharma Expands Capital Through Employee Warrant Exercise
  • Understanding Northann Corp's Response to Stock Market Fluctuations
  • Arcutis Biotherapeutics Awards Restricted Stock Units to New Hires
  • Magnetic North's Recent Updates on Management Trading Status
  • Broadway Technology Merges with Quartzsea Acquisition Corp
  • Playa Hotels & Resorts Confirms Antitrust Approval Ahead of Sale
  • Genpact Limited Announces Quarterly Cash Dividend Increase
  • DICK'S Sporting Goods Initiates Exchange Offer for Foot Locker Debt
  • Replimune's Innovative Employee Inducement Strategy
  • Keros Therapeutics to Showcase Innovations at Health Conference
  • Enovis Corporation to Showcase Innovations at Investor Events
  • Breaking Down TELA Bio's New Stock Options for Leadership Team
  • PolyPid's Upcoming Call on D-PLEX100 Trial Results and Insights
  • Globalink Investment Extends Business Combination Deadline Effectively
  • 89bio Approves New Stock Options Grant for Employees
  • Rakovina Therapeutics Secures $4.9 Million Through Private Placement
  • SRQ Resources Inc. Reports Successful Shareholder Meeting Results
  • Opendoor's Proxy Filing: Revolutionizing Real Estate with Confidence
  • Investors Urged to Join Ibotta, Inc. Class Action Lawsuit
  • Leading NAPCO Security Technologies Class Action Opportunities
  • Kennametal Completes Strategic Sale of Subsidiary, Boosting Growth
  • Spyre Therapeutics Grants Stock Options to Boost Team Growth
  • Kojamo Announces Sale of 44 Residential Properties for EUR 242M
  • Strategic Leadership Shift: Matt Mayfield as CEO of Camwood
  • SKEL Transaction Enhances Strategic Shareholder Base in Styrkás
  • Treace Medical Concepts Class Action: A Chance for Investors
  • Marsai Martin and Seeds of Fortune Unite to Empower Women
  • Revolutionizing Safety and Nutrition with Wild About Sprouts
  • Essential Insights on BigBear.ai Holdings Investors' Rights
  • Teamsters Expanded Strike at Sutphen Corporation Headquarters
  • Review of Silvano Fashion Group's 2024 Annual Financial Report
  • Synthetic Grass Warehouse Expands with a New Atlanta Facility
  • Ally Walker's 'The Light Runner' Challenges Perception in Fiction
  • Dionisio Gutiérrez Honored with Prestigious Award by Spain's King
  • Investors in Zenas BioPharma Urged to Join Class Action Lawsuit
  • Celebrating the Historic Reopening of Dianetics Landmark Site
  • PG&E's Vision for a Safer Future: Wildfire Preparedness Insights
  • Revolutionizing Church Interactions with Subsplash Tap Technology
  • Kwanza Jones Celebrates Teyana Taylor with Innovator Award
  • Dionisio Gutiérrez Honored with Prestigious Award by Spain
  • StarKist and Feed the Children Host Food Resource Event
  • La Bronca Joins reVolver Podcasts to Empower Communities
  • Innovative Study Revolutionizes Colorectal Cancer Treatment Options
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site